Transaction overview
On November 22, 2022, Ever.Ag, a US-based AgTech company focused on empowering agricultural supply chains, completed its acquisition of Dalex, also based in the United States. Dalex is a pioneer in animal nutrition technology, offering advanced feed ration formulation tools since 1980. The transaction's financial details were not disclosed, but it represents Ever.Ag’s strategic move to enhance its suite of on-farm solutions for livestock and dairy producers.
Deal structure and financing
The acquisition of Dalex by Ever.Ag did not disclose specific terms regarding equity or debt split, as well as any lead banks involved in the deal. Given the undisclosed value of the transaction, no leverage metrics were provided. It is unclear if there was a seller's retained stake or lock-up agreement for key personnel from Dalex post-acquisition. No information on potential IPO optionality was mentioned either.
Strategic context
Ever.Ag’s acquisition of Dalex aligns with its broader strategy to enhance the efficiency and sustainability of agricultural supply chains, particularly in livestock and dairy sectors where feed costs are a significant expense for producers. The rationale behind Ever.Ag's move is clear: integrating Dalex’s advanced ration balancing tools enables farmers to optimize their feeding practices, thereby reducing costs and improving animal productivity.
From Dalex's perspective, the transaction represents an opportunity to join forces with a larger entity that can scale its technology solutions across a wider customer base. By becoming part of Ever.Ag, Dalex gains access to broader market reach and complementary technologies such as Cainthus for real-time feed management and analytics platforms for performance monitoring. This strategic partnership aims to deliver end-to-end visibility into farm operations, enhancing the overall value proposition for livestock producers.
Regulatory path
The acquisition of Dalex by Ever.Ag did not require significant regulatory scrutiny given its nature within the specialized agricultural technology sector. The transaction was likely reviewed in the United States under the Hart-Scott-Rodino Antitrust Improvements Act (HSR), though no specific filings or review timelines were disclosed. Given the targeted and niche focus of Dalex’s offerings, it is unlikely that any remedies were required to address competition concerns.
Ever.Ag's acquisition strategy continues to be focused on adding value through technological integration rather than market dominance in broad agricultural segments. As such, regulatory hurdles are expected to remain minimal for similar future deals within Ever.Ag's strategic growth framework.